[HTML][HTML] The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in …
JC Mewes, MS Pulia, MK Mansour, MR Broyles… - PLoS …, 2019 - journals.plos.org
Background Procalcitonin is a biomarker that supports clinical decision-making on when to
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A …
JC Mewes, MS Pulia, MK Mansour, MR Broyles… - PLoS …, 2019 - search.ebscohost.com
Background: Procalcitonin is a biomarker that supports clinical decision-making on when to
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A …
JC Mewes, MS Pulia, MK Mansour, MR Broyles… - PloS …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Procalcitonin is a biomarker that supports clinical decision-making on when to
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A …
JC Mewes, MS Pulia, MK Mansour, MR Broyles… - Plos one, 2019 - europepmc.org
Background Procalcitonin is a biomarker that supports clinical decision-making on when to
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
[引用][C] The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the …
JC Mewes, MS Pulia, MK Mansour, MR Broyles… - PLoS …, 2019 - ui.adsabs.harvard.edu
The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised
patients with suspected sepsis or lower respiratory tract infections in the US: A health …
patients with suspected sepsis or lower respiratory tract infections in the US: A health …
The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A …
JC Mewes, MS Pulia, MK Mansour, MR Broyles… - PLOS ONE, 2019 - ideas.repec.org
Background: Procalcitonin is a biomarker that supports clinical decision-making on when to
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
[PDF][PDF] The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the …
JC Mewes, MS Pulia, MK Mansour… - PLoS …, 2019 - pdfs.semanticscholar.org
Background Procalcitonin is a biomarker that supports clinical decision-making on when to
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
[引用][C] The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the …
JC Mewes, MS Pulia, MK Mansour… - PLoS …, 2019 - lomalinda.elsevierpure.com
The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised
patients with suspected sepsis or lower respiratory tract infections in the US: A health …
patients with suspected sepsis or lower respiratory tract infections in the US: A health …
The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: a …
JC Mewes, MS Pulia, MK Mansour, MR Broyles… - 2019 - cabidigitallibrary.org
Background: Procalcitonin is a biomarker that supports clinical decision-making on when to
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
[HTML][HTML] The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in …
JC Mewes, MS Pulia, MK Mansour, MR Broyles… - PLoS ONE, 2019 - ncbi.nlm.nih.gov
Background Procalcitonin is a biomarker that supports clinical decision-making on when to
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …
initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been …